• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    More On SAC.DE



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Sanochemia Pharmazeutika AG (SAC.DE)

    1.40 Up 0.04(2.87%) Feb 12, 11:35AM EST
    ProfileGet Profile for:
    Sanochemia Pharmazeutika AG
    Boltzmanngasse 11
    Vienna, 1090
    Austria - Map
    Website: http://www.sanochemia.at

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:151

    Business Summary 

    SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients; sterile and semi-sterile liquid, and semi-liquid presentations, such as antibiotics and hormones; clinical diagnostics; and veterinary pharmaceuticals, as well as radiological products, including a range of X-ray imaging agents and the MRT imaging agents. The company’s products include Tolperisone, a muscle relaxant; and galantamine that is used in an Alzheimer's disease. It also researches and develops in therapeutic areas, such as painful muscle spasms/spasticity, and bladder cancer diagnostic; and offers contract manufacturing services. The company was founded in 1990 and is headquartered in Vienna, Austria.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sanochemia Pharmazeutika AG

    Key Executives 
    Ms. Eveline Frantsits ,
    Chairwoman of the Supervisory Board and Exec. Officer
    Dr. Werner Josef Frantsits Ph.D.,
    Founder, Chief Exec. Officer, Pres of The Management Board and Head of Veterinary Medicine and Strategic Management
    Dr. Johannes M. Respondek ,
    Managing Director and Vice-Pres of The Supervisory Board
    Dr. Heinrich Unger-Krayer ,
    Exec. Officer and Member of the Supervisory Board
    Stefan Welzig ,
    Chief Financial Officer, Chief Technical Officer and Head of Production & Technology and Fin. and Member of The Management Board
    Amounts are as of Dec 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.